8
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Calidad de vida en pacientes con tumores cerebrales: importancia de las variables psicológicas Translated title: Quality of life in patients with gliomas: the role of psychological variables

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Los síntomas clínicos de ansiedad y depresión, así como el deterioro cognitivo determinan la calida de vida de los pacientes con tumores cerebrales (Liu, Page, Solheim, Fox y Chang, 2009). El objetivo de este estudio es analizar la calidad de vida y su relación con diferentes variables psicológicas en individuos diagnosticados de glioma hace seis meses. La muestra estuvo formada por 28 pacientes (58.6% hombres) con una edad media de 54.38 años, el 89.2% de los cuales estaba recibiendo tratamiento oncológico adyuvante. A todos ellos se les aplicó un protocolo de valoración con un instrumento de calidad de vida y una batería neuropsicológica (ansiedad y depresión, orientación, atención, memoria, lenguaje, gnosias y funciones ejecutivas). Los pacientes del estudio presentaron una peor calidad de vida en determinadas dimensiones (física, familiar, funcional) y en la percepción global de bienestar. Todas las áreas de la calidad de vida se asocian con variables de estado de ánimo y la presencia de manifestaciones clínicas de depresión explica una deficitaria calidad de vida. Por otra parte, el mejor rendimiento cognitivo de los pacientes con gliomas en procesos de reconocimiento de objetos, memoria y planificación indica una mayor calidad de vida global de dichos pacientes.

          Translated abstract

          Clinical symptoms of anxiety and depression as well as cognitive impairment determine the quality of life of patients with brain tumors (Liu, Page, Solheim, Fox, & Chang, 2009). The aim of this paper is to analyze the quality of life and its relationship to psychological variables in individuals diagnosed with glioma six months earlier. The sample consisted of 28 patients (58.6 % male) with a mean age of 54.38 and 89.2 % of them receiving adjuvant therapy (chemotherapy). All subjects were administered a neuropsychological battery assessing quaility of life, anxiety and depression, attention, memory, language, visuoconstructive skills, visual organization, language, and executive functions. These patients have a worse quality of life in certain dimensions (physical, functional, family) and overall perception of well-being. All areas of quality of life are associated with mood and the presence of clinical manifestations of depression accounts for a lower quality of life. On the other hand, improved cognitive performance in object recognition processes, memory, and planning indicates a higher overall quality of life of these patients.

          Related collections

          Most cited references51

          • Record: found
          • Abstract: found
          • Article: not found

          The prevalence of psychiatric disorders among cancer patients.

          Two hundred fifteen randomly accessed cancer patients who were new admissions to three collaborating cancer centers were examined for the presence of formal psychiatric disorder. Each patient was assessed in a common protocol via a psychiatric interview and standardized psychological tests. The American Psychiatric Association's DSM-III diagnostic system was used in making the diagnoses. Results indicated that 47% of the patients received a DSM-III diagnosis, with 44% being diagnosed as manifesting a clinical syndrome and 3% with personality disorders. Approximately 68% of the psychiatric diagnoses consisted of adjustment disorders, with 13% representing major affective disorders (depression). The remaining diagnoses were split among organic mental disorders (8%), personality disorders (7%), and anxiety disorders (4%). Approximately 85% of those patients with a positive psychiatric condition were experiencing a disorder with depression or anxiety as the central symptom. The large majority of conditions were judged to represent highly treatable disorders.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Quality of life in adults with brain tumors: current knowledge and future directions.

            Quality of life is an important area of clinical neurooncology that is increasingly relevant as survivorship increases and as patients experience potential morbidities associated with new therapies. This review of quality-of-life studies in the brain tumor population aims to summarize what is currently known about quality of life in patients with both low-grade and high-grade tumors and suggest how we may use this knowledge to direct future research. To date, reports on quality of life have been primarily qualitative and focused on specific symptoms such as fatigue, sleep disorders, and cognitive dysfunction, as well as some symptom clusters. However, the increasing interest in exploring quality of life as a primary end point for cancer therapy has established a need for prospective, controlled studies to assess baseline and serial quality-of-life parameters in brain tumor patients in order to plan and evaluate appropriate and timely interventions for their symptoms.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors.

              This report describes the development and validation of a brain subscale for the Functional Assessment of Cancer Therapy (FACT) scale, and the revalidation of the subscales of the general version (FACT-G), which measure physical, social, family, emotional, and functional well-being and the quality of the relationship with the physician. 101 patients with primary brain tumors, after giving informed consent, participated in the last two phases of a four-phase validation process: item generation, item reduction, validation, and reliability testing. In the validation phase, FACT-G subscale and total scores as well as the brain subscale scores were correlated with other tests of mood, response, bias, and quality of life (QOL). Test-retest reliability testing was performed with 46 patients who had primary brain tumors. Validity and reliability coefficients were high for the FACT-G and brain subscale, except for the comparison with a second QOL measure (FP-QLI) and the Karnofsky Performance Status (KPS). The lower scores were the result of inherent differences in the two QOL instruments and the relatively high performance status of the brain tumor patients, which restricted the KPS score range. The FACT-G has good psychometric properties supporting its broad generalizability and the brain subscale tests substantially different QOL issues than the core instrument. Use of this scale with the addition of the brain subscale provides a well rounded view of the various aspects of QOL from the patient's perspective. With modifications and further psychometric testing, the brain subscale may have broader applicability to subpopulations of patients with other brain disorders.
                Bookmark

                Author and article information

                Contributors
                Role: ND
                Role: ND
                Journal
                clinsa
                Clínica y Salud
                Clínica y Salud
                Colegio Oficial de Psicólogos de Madrid (Madrid, Madrid, Spain )
                1130-5274
                2174-0550
                March 2015
                : 26
                : 1
                : 23-32
                Affiliations
                [02] orgnameHospital Clínico San Carlos orgdiv1Servicio de Obstetricia y Ginecología
                [01] orgnameFundación Grupo IMO (Instituto Madrileño de Oncología) orgdiv1Unidad de Neurooncología España
                [03] Madrid orgnameUniversidad Complutense de Madrid España
                Article
                S1130-52742015000100004
                10.1016/j.clysa.2014.07.003
                88420b62-3adc-45f8-9530-eab38883b2ba

                This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 International License.

                History
                : 14 July 2014
                : 21 May 2014
                : 18 June 2014
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 30, Pages: 10
                Product

                SciELO Spain


                Calidad de vida,Glioma,Ansiedad y depresión,Rendimiento cognitivo,Quality of life,Anxiety and depression,Cognitive performance

                Comments

                Comment on this article